About Micron Biomedical
Micron Biomedical is a Healthcare company based in Atlanta (United States) founded in 2014. Microneedle patches are developed for vaccine and drug delivery. Micron Biomedical has raised $33 million across 5 funding rounds from investors including UNICEF, Centers for Disease Control and Prevention and Gates Foundation. The company has 11 employees. Micron Biomedical offers products and services including Dissolvable Microarray Technology and Thermostable Vaccine Delivery. Its focus areas include Life Sciences, Drug Delivery, Patches and Microneedle Patch. Its legal entity is Micron Biomedical, Inc. Its competitors include Enable Injections, Zosano Pharma and SkinJect; 3 of its 3 listed competitors have raised funding.
Company details
Micron Biomedical was founded in 2014 in Atlanta, United States, within the biomedical sector. Focus is placed on microneedle patch technology that enables minimally invasive delivery of vaccines and drugs. The patches penetrate upper skin layers and dissolve quickly, supporting targeted therapeutic applications. Operations center on advancing this delivery method for improved efficacy in healthcare settings.
- Headquarters Atlanta, United States
- Employees 11
- SectorsHealthcare
- Email••••••••
- Website micronbiomedical.com
- Social LinkedIn Facebook
- Legal Name Micron Biomedical, Inc.
- Total Equity Funding$33M (USD)
in 5 rounds
- Latest Funding Round$2M (USD), Grant
Jan 2025
- InvestorsUNICEF
& 8 more
- Employee Count11
Products & Services of Micron Biomedical
Micron Biomedical offers a comprehensive portfolio of products and services, including Dissolvable Microarray Technology and Thermostable Vaccine Delivery.
Enables needle-free administration of vaccines and therapeutics globally.
Provides stable, needle-free solutions for vaccine distribution and use.
Funding Insights of Micron Biomedical
Micron Biomedical has successfully raised a total of $33M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $2 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $33M
- Total Rounds 5
- Last Round Grant — $2M
- First Round $14M
(Nov 2022)
- Investors Count 9
All 5 funding rounds of Micron Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | $2M | Grant | – | – | |
| Dec 2024 | $16M | Series A | – | J2 Ventures | |
| Nov 2023 | $23.6M | Grant | – | – | |
| Apr 2023 | $3M | Series A | – | – | |
| Nov 2022 | $14M | Series A | – | LTS Lohmann, Global Health Investment |
9 investors in total: 9 institutional.
Investors in Micron Biomedical
Micron Biomedical has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include UNICEF, Centers for Disease Control and Prevention and Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in tech startups are made by J2 Ventures. | j2vp.com | New York, United States | ||
Seed & early stage sector-agnostic venture capital firm funding companies in the US | graventurefund.org | Atlanta, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Global health technologies are supported through strategic investments. | ghicfunds.org | |||
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States | |
Drug delivery systems targeting multiple disease indications are developed. | 1997 | ltslohmann.com | Caldwell, United States | |
Global health solutions are developed and delivered to enhance outcomes. | 1977 | path.org | United States | |
Humanitarian services are provided by UNICEF in developing countries. | 1946 | unicef.org | United States | |
Disease control and prevention services are provided nationwide. | 1946 | cdc.gov | United States |
Investor details for Micron Biomedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Micron Biomedical
5 people are tracked at Micron Biomedical (4 in leadership, 1 in team); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Steve Damon | Chief Executive Officer | Leadership |
Idean Marvasty | Chief Financial Officer | Leadership |
Devin McAllister | Evp, CTO & Co-founder | Leadership |
Stephanie Adams | Director, Intellectual Property & Grants | Leadership |
Winston Pewin | Principal Development Engineer | Team |
Complete people profiles for Micron Biomedical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Micron Biomedical
3 dated milestones of Micron Biomedical across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Micron Biomedical is founded.
- Funding First funding round of $14.0M.
- Funding Latest funding round, Grant, of $2.0M.
Competitors of Micron Biomedical
Micron Biomedical has 3 listed competitors in our database, 3 of them funded. They include Enable Injections, Zosano Pharma and SkinJect.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enableinjections.com | 2010 | Cincinnati, United States | $304.27M | 185 | Provider of a wearable drug delivery solution | |
| zosanopharma.com | 2006 | Fremont, United States | $147.16M | 40 | Develops innovative transdermal drug delivery technologies for various therapeutic applications. | |
| skinjectpatch.com | 2015 | Pittsburgh, United States | $3.4M | Dissolvable microneedle patches for non-melanoma skin cancer treatment are developed. |
Detailed competitors of Micron Biomedical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Micron Biomedical
The website of Micron Biomedical (micronbiomedical.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▼ 20.6% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Micron Biomedical (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Micron Biomedical
Complete news archive for Micron Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Micron Biomedical
Micron Biomedical was founded in 2014 and raised its 1st funding round 8 years after it was founded.
Micron Biomedical is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Micron Biomedical is a funded company, having raised a total of $33M across 5 funding rounds to date. The company's 1st funding round was a Series A of $14M, raised on Nov 2022.
Micron Biomedical has 11 employees.
Micron Biomedical was founded in 2014 in Atlanta, United States, within the biomedical sector. Focus is placed on microneedle patch technology that enables minimally invasive delivery of vaccines and drugs. The patches penetrate upper skin layers and dissolve quickly, supporting targeted therapeutic applications. Operations center on advancing this delivery method for improved efficacy in healthcare settings.
Micron Biomedical's top competitors include Enable Injections, SkinJect and Zosano Pharma.
Micron Biomedical offers Dissolvable Microarray Technology and Thermostable Vaccine Delivery.
Micron Biomedical has 9 investors. Key investors include UNICEF, Centers for Disease Control and Prevention, Gates Foundation, HHS, and Path.
Micron Biomedical operates through Micron Biomedical, Inc..